DANIEL J. HICKLIN - 02 Jan 2025 Form 4 Insider Report for Werewolf Therapeutics, Inc. (HOWL)

Role
President and Chief Executive Officer, Director
Signature
/s/ Jonathan Owen, Attorney-in-fact
Issuer symbol
HOWL
Transactions as of
02 Jan 2025
Net transactions value
$0
Form type
4
Filing time
06 Jan 2025, 17:41:13 UTC
Previous filing
04 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOWL Stock Option (right to buy) Award $0 +592,690 $0.000000 592,690 02 Jan 2025 Common Stock 592,690 $1.56 Direct F1
transaction HOWL Stock Option (right to buy) Award $0 +185,652 $0.000000 185,652 02 Jan 2025 Common Stock 185,652 $1.56 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on January 2, 2025 with a Vesting Commencement Date of January 1, 2025. The shares underlying the option vest in equal monthly installments over four years, with the initial vesting to commence on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2029.

Remarks:

President and Chief Executive Officer